Status:
RECRUITING
Exploring Parameters of Driving Simulation in Relation to Drug Holidays in ADHD Patients
Lead Sponsor:
Stefan Lakämper
Collaborating Sponsors:
Psychiatric University Hospital, Zurich
Swiss Federal Institute of Technology in Zurich (ETHZ)
Conditions:
ADHD - Attention Deficit Disorder With Hyperactivity
Driving Simulator Performance
Eligibility:
All Genders
10+ years
Phase:
NA
Brief Summary
Attention deficit hyperactivity disorder (ADHD) or syndrome (ADHS) is a symptomatically defined condition that - if untreated - is linked to a significantly increased risk of traffic accidents. In a r...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- adult drivers
- ADHD-diagnosed, established ADHD-treatment only with stimulants
- known history of drug holidays based on own decision,
- at impaired eyesight with more than +/- 5 diopter or astigmatism
- contact lenses are required (for eye tracking)
- Exclusion criteria:
- sensibility to motion sickness (kinetosis, dizziness etc. in 5 min screening drive)
- non-stimulant-treatment
- inability to understand the study procedure for linguistic or cognitive reasons
- professional drivers (if working during the study period)
- for women: pregnancy
Exclusion
Key Trial Info
Start Date :
June 2 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2026
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT06910605
Start Date
June 2 2025
End Date
October 31 2026
Last Update
June 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Traffic Medicine, Institute of Forensic Medicine, University of Zurich,
Zurich, ZRH, Switzerland, 8050